We analyze market access trends and market readiness challenges while providing brand and market access solutions to navigate the rapidly changing healthcare market.
Real-World Data
MMIT integrates medical and pharmacy claims, lab tests and results, electronic health records, and clinical pathways data and links them to payer coverage data to create a unified record of patients, providers, therapies, treatments and results.
Access a proactive, economic, precise, and comprehensive solution to help manufacturers promote their therapies to specific providers using lab test results before a diagnosis or prescribing decision is made.
For nearly three decades, MMIT has been a leading provider of market access data, analytics and insights. MMIT is a trusted go-to-market partner that identifies barriers to patient access and helps coordinate major stakeholders to move therapies from pipeline to patient—answering the “what” of how payers cover therapies and the “why” behind those decisions.
Features
Thought Leadership
Industry Leading Insights
Get the latest insights on industry trends and hot topics like the Inflation Reduction Act, the Medicare Drug Price Negotiation Program, vaccine approvals, drug shortages, and more.
What Pharma Wants to Know About the Inflation Reduction Act
In many ways, the IRA is forcing a marriage of necessity between product development and market access, as manufacturers must now be more focused on anticipating future market states for their potential and existing pipeline.